$CAC

Camden National Corporation Reports Record Quarterly Net Income of $23.0 Million and Diluted EPS of $1.35 for the Second Quarter of 2026

Camden National Corporation (NASDAQ: CAC) reported Q2 2026 net income of $23.0 million and diluted EPS of $1.35 for the quarter ended June 30, 2026. For the first six months, net income was $44.9 million and diluted EPS $2.64. The company cited 3% annualized loan growth, net interest margin at 3.26%, and a $0.42/share dividend, plus a Q2 buyback of 52,000 shares.

Original reporting
Published Jul 28, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 12:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Camden National Corporation Reports Record Quarterly Net Income of $23.0 Million and Diluted EPS of $1.35 for the Second Quarter of 2026 — source image
Decision brief

The 30-second read

$CACBullishMed
01

Why it matters

The combination of record GAAP net income/EPS, NIM expansion driven by lower funding costs, improved non-interest income, and a declared dividend creates a clear near-term catalyst for CAC positioning and valuation expectations.

02

Market read

Traders can update CAC expectations for profitability, net interest income trajectory, and capital return based on the specific Q2 metrics and announced dividend/buyback.

03

What to watch

The PR highlights strong asset quality and ACL coverage, but it does not quantify forward credit outlook or discuss any changes in guidance beyond general strategy language, which may limit how far the market extrapolates.

Relevance 8/10Novelty 8/10Timing: after-hours/at release of Q2 2026 earnings PR (July 28, 2026)

Background

Camden National is a Northern New England community bank holding company; this release reports Q2 2026 results and first-half performance, including capital return actions.

Company-level read

Ticker impact

$CACBullishMedium confidence
Context

Camden National reported Q2 2026 net income of $23.0M and diluted EPS of $1.35, plus NIM expansion to 3.26% and a $0.42 dividend.

Expected impact

Likely positive bias for CAC as investors price in record earnings, NIM expansion, and capital return (buyback plus dividend).

Evidence & confidence

The article provides multiple concrete, linked-quarter operating metrics (NIM +2 bps to 3.26%, non-interest income +21%, efficiency ratios slightly improved) and explicit capital actions (52k-share buyback, $0.42 dividend with stated record/pay dates).

Market effects

Adds a data point on community bank profitability drivers (funding cost pressure easing, NIM expansion, stable asset quality).

Reinforces sentiment toward Northern New England bank holding companies via demonstrated earnings momentum and capital strength.

Limited global spillover; primarily relevant to US regional banking and rate-sensitive net interest income expectations.

Counterpoint

Despite record earnings, loans grew only 1% and deposits declined 1%, so the sustainability of NIM gains may be questioned if funding costs or deposit trends reverse.

Key entities

  • Camden National Corporation

    Reported Q2 2026 record net income of $23.0M and diluted EPS of $1.35, with NIM expansion to 3.26% and a $0.42 dividend.

Related articles

$CACMed

Camden National Q2 Earnings Call Highlights

Camden National (NASDAQ:CAC) Q2 earnings call covered loan and deposit trends and guidance. Archer said quarterly cash flows modeled at about $35M from investments and $170M to $180M from loans, with new loan pricing in the low-6% to 6.5% range. Noninterest income rose 21% to $14.5M; Q3 outlook $13.5M to $14M. Assets were $7B; deposits $5.6B; tangible book value per share $31.64.

Med

Camden National Corporation Q2 2026 Earnings Call Summary

Camden National Corporation reported record Q2 2026 net income of $23 million, citing loan growth, a 2 bp net interest margin expansion from lower funding costs and deposit mix, and 21% linked-quarter fee income growth. HELOC balances rose 23% YoY, and management expects Q3 NIM up 5 to 10 bp, noninterest income $13.5m to $14m, and expenses $37m to $38m.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.